Nutriband Inc. Common Stock (NTRB) is a publicly traded Healthcare sector company. As of May 21, 2026, NTRB trades at $3.53 with a market cap of $41.57M and a P/E ratio of -1.36. NTRB moved +2.32% today. Year to date, NTRB is -21.21%; over the trailing twelve months it is -36.85%. Its 52-week range spans $3.40 to $11.78. Analyst consensus is buy with an average price target of $15.00. Rallies surfaces NTRB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NTRB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NTRB recently traded at $3.53. Market cap is $41.57M. P/E ratio is -1.36. Revenue is $2.04M.
| Metric | Value |
|---|---|
| Price | $3.53 |
| Market Cap | $41.57M |
| P/E Ratio | -1.36 |
| EPS | $-2.58 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.78 |
| 52-Week Low | $3.40 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.04M |
| Net Income | $-8.23M |
| Gross Margin | 27.81% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $2.04M | $-8.23M | $-2.58 |
| 2025 | $2.14M | $-10.48M | $-0.99 |
| 2024 | $2.09M | $-5.49M | $-0.69 |
| 2023 | $2.08M | $-4.48M | $-0.53 |
1 analysts cover NTRB: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $15.00.